Search for other papers by Xian Qiu in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China
Search for other papers by Ri Sa in
Google Scholar
PubMed
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Hao Fu in
Google Scholar
PubMed
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
Introduction Thyroid cancer is responsible for 586,000 cases worldwide, ranking the ninth place for incidence in 2020, with differentiated thyroid cancer (DTC) accounting for over 90% ( 1 ). For DTC at an early stage, the optimal prognosis is
Center for Health Technology and Services Research (CINTESIS), Porto, Portugal
Search for other papers by Claudia Matta-Coelho in
Google Scholar
PubMed
Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Joana Simões-Pereira in
Google Scholar
PubMed
Search for other papers by Helena Vilar in
Google Scholar
PubMed
Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Introduction The incidence of thyroid cancer has increased in the last few decades, with an average estimated incidence in 2012 of 20.0 cases per 100,000 in women and 6.3 cases per 100,000 in men [ 1 ]. Thyroid cancer is now the most common
Search for other papers by Kirsten E. Stewart in
Google Scholar
PubMed
Search for other papers by Mark W.J. Strachan in
Google Scholar
PubMed
Search for other papers by Devraj Srinivasan in
Google Scholar
PubMed
Search for other papers by Morna MacNeill in
Google Scholar
PubMed
Search for other papers by Lucy Wall in
Google Scholar
PubMed
Search for other papers by Iain J. Nixon in
Google Scholar
PubMed
thyroid cancer (DTC) is increasing in incidence, with the most marked increase seen in small volume, low-risk lesions [ 1 ]. However, an increase in more advanced disease has also been reported [ 2 , 3 ]. The majority of patients present with disease
Search for other papers by Nandhini Lakshmana Perumal in
Google Scholar
PubMed
Search for other papers by Jayakumar Selvi in
Google Scholar
PubMed
Search for other papers by Kalyani Sridharan in
Google Scholar
PubMed
Search for other papers by Jayaprakash Sahoo in
Google Scholar
PubMed
Search for other papers by Sadishkumar Kamalanathan in
Google Scholar
PubMed
Introduction Graves’ disease (GD) is one of the most commonly encountered disorders in clinical practice with an annual incidence of 20–50 cases per 100,000 persons [ 1 ]. Thyroid hormones (THs) play a key role in intermediate metabolism, and
Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Lars Folkestad in
Google Scholar
PubMed
Search for other papers by Frans Brandt in
Google Scholar
PubMed
Search for other papers by Thomas Brix in
Google Scholar
PubMed
Search for other papers by Marianne Vogsen in
Google Scholar
PubMed
Search for other papers by Lars Bastholt in
Google Scholar
PubMed
Search for other papers by Peter Grupe in
Google Scholar
PubMed
Search for other papers by Jeanette Krogh Petersen in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
:661–666. 10.1001/archinte.160.5.661 10724051 5 Wiersinga WM: Smoking and thyroid. Clin Endocrinol (Oxf) 2013; 79:145–151. 10.1111/cen.12222 23581474 6 Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G: High incidence of multinodular toxic
Search for other papers by Eyun Song in
Google Scholar
PubMed
Search for other papers by Jonghwa Ahn in
Google Scholar
PubMed
Search for other papers by Hye-Seon Oh in
Google Scholar
PubMed
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Search for other papers by Won Bae Kim in
Google Scholar
PubMed
Search for other papers by Young Kee Shong in
Google Scholar
PubMed
Search for other papers by Tae Yong Kim in
Google Scholar
PubMed
Introduction The incidence of body weight change (BWC) in patients with overt thyroid dysfunction exceeds 50%, representing one of the most common symptoms [ 1 , 2 ]. Overt hyperthyroidism (OHyper) is frequently associated with weight loss
FMTS, Faculté de Médecine, Université de Strasbourg, Strasbourg
Search for other papers by Bernard Goichot in
Google Scholar
PubMed
Search for other papers by Stéphane Bouée in
Google Scholar
PubMed
Search for other papers by Claire Castello-Bridoux in
Google Scholar
PubMed
Inserm U1037, Université Paul Sabatier, Toulouse, France
Search for other papers by Philippe Caron in
Google Scholar
PubMed
confirm the potential gain in terms of rapidity of achieving euthyroidism, the reduction in the number of laboratory monitoring thyroid tests, and the real incidence of hematological and hepatic adverse effects. In conclusion, our study is the first
Search for other papers by C. Daumerie in
Google Scholar
PubMed
Search for other papers by A. Boschi in
Google Scholar
PubMed
Search for other papers by P. Perros in
Google Scholar
PubMed
, 9 , 10 ]. Several studies have demonstrated an increased incidence of nodules and of thyroid cancer (particularly well-differentiated carcinomas) in patients with Graves’ disease (GD), with reported cancer rates of 1–9% [ 11 , 12 ]. The coexistence
Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed
Search for other papers by Daniela Pierannunzio in
Google Scholar
PubMed
Search for other papers by Silvia Francisci in
Google Scholar
PubMed
Search for other papers by Angela De Paoli in
Google Scholar
PubMed
Search for other papers by Federica Toffolutti in
Google Scholar
PubMed
Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed
Search for other papers by Silvia Franceschi in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Ugo Fedeli in
Google Scholar
PubMed
Search for other papers by of the DEPTH Working Group in
Google Scholar
PubMed
in absolute numbers, from 5220 RAI treatments in 2016 to 4219 in 2018 (Supplementary Table 1). Supplementary Table 2 and Supplementary Fig. 1 show incidence rates of RAI after TT per 100,000 women and men in Italy, overall and by age, all descreasing
Search for other papers by Marta Amaro da Silveira Duval in
Google Scholar
PubMed
Search for other papers by André Borsatto Zanella in
Google Scholar
PubMed
Search for other papers by Ana Patrícia Cristo in
Google Scholar
PubMed
Search for other papers by Carlo Sasso Faccin in
Google Scholar
PubMed
Search for other papers by Marcia Silva Graudenz in
Google Scholar
PubMed
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
, responsible for more than 80% of the cases [ 2 ]. While there is a consensus that the increasing use of imaging examinations contributes to the rising detection of subclinical disease, there is also an increased incidence of DTC of all sizes, including larger